Higher Education Essay Example for Free

Higher Education Essay Economic Crisis and Higher Education in the United States The 2008–2012 economic failure is considered by many economists and investors to be the worst financial crisis since the Great Depression of the 1930s. It results in the risk of total collapse from big financial firms, the bailout of banks by national governments, and downturns in stock markets around the world. The crisis also plays a significant role in the crash of key businesses and collapse of housing market, results in the delayed unemployment. Higher education is a large and various venture in the United States, which has impacted by the economic recession in a number of ways, but these impacts have not been the same and vary depending on state and type of institution. Most higher education traditions started to be concerned about their financial problems due to economic recession. Their main source of revenue has been hurt by the downturn, and that those universities would need to make hard decisions about how to spend their money. In some states, a lot of institutions are in process of fund-raising programs to avoid delaying their supported campus building projects. Many of higher education university’s leaders have been considering and solving of two following questions: How is the economic downturn affecting institutions both public and private? What strategies are leaders implementing to guide their institutions? Unsuccessful budget strategies are the main reason that caused many institutions’ problems. Their top managers have not effectively managed their money. Fund-raising, government support, and earned income will also suffer in a poor economy. They are also experiencing revenue deficits due to lower state appropriations, endowment losses, or a reduction in donation. Furthermore, institutions difficulties in gaining access to funds invested in a major short-term investment fund. According to Ken Chabotar, author of The Economy and Higher Education, budget management is related to the most complicated set of relationships in higher education are among college costs, student tuition fees, financial aid, and enrollment. Quality plus financial aid and affordability are the issues that most colleges and universities worry how much economics will affect while thinking about to limit costs and prices. In the current economic situation, adults and recent high-school graduates are willing to study for two years at a community college make more financial sense than going straight to a more expensive campus. Community colleges as known as lower cost institutions are recognizing a rise in enrollment levels while small, independent colleges and universities result in a fall in enrollment. As a result, the economic crisis creates hardship not only for students in paying their tuition and also difficulties for higher education institutions to maintain their enrollment level, especially their budget and revenue. Additionally, many of well-known universities such as Harvard, Yale, and Princeton etc. are facing difficult financial problems due to cut of endowment and donation from investors and alumni. Well-endowed institutions have suffered losses up to a third of market value and 30% of donated money compelling budget cuts, wage freezes, and borrowing to support the operating budget rather than increase endowment spending. In the United States, there are a lot of campus relied on endowment too much. Many universities have been delayed on cash funding of appropriations from state and federal government. The top managers have to suspense almost half of capital projects and research in order to balance their institutions’ budget. Loss of enrollment and endowment in higher education increases the financial needs of university in order to afford their expenses and keep operation going.

VDEC Based Data Extraction and Clustering Approach

VDEC Based Data Extraction and Clustering Approach This chapter describes in details the proposed VDEC Approach. It discusses the two phases of the VDEC process for Data Extraction and clustering. Experimental performance evaluation results are shown in the last section in comparing the GDS and SDS datasets. INTRODUCTION Extracting data records on the response pages returned from web databases or search engines is a challenge posed in information retrieval. Traditional web crawlers focus only on the surface web while the deep web keeps expanding behind the scene. Vision based data extraction provides a solution to extract information from dynamic web pages through page segmentation for creating a data region and data record and item extraction. A vision based web information extraction systems become more complex and time-consuming. Detection of data region is a significant problem for information extraction from the web page. This chapter discusses an approach to vision-based deep web data extraction and web document clustering. The proposed approach comprises of two phases, (1) Vision-based web data extraction, and (2) web document clustering. In phase 1, the web page information is segmented into various chunks. From which, surplus noise and duplicate chunks are removed using three parameters, such as hyperlink percentage, noise score and cosine similarity. Finally, the extracted keywords are subjected to web document clustering using Fuzzy c-means clustering (FCM). VDEC APPROACH VDEC approach is designed to extract visual data automatically from deep web pages as shown in the block diagram in figure 5.1. Figure 5.1 – VDEC Approach Block diagram In most of web pages, there will be more than one data object tied together in data region, makes difficult to search attributes for each page. Unprocessed source of web page for representing the objects is non-contiguous one, the problem becomes more complicated. In existent applications, the users necessitate from complex web pages is the description of individual data object derived from the partitioning of the data region. VDEC achieve the data capturing from the deep web pages using two phases as discussed in the following sections. Phase-1 Vision Based Web Data Extraction In Phase-1 VDEC approach performs data extraction and a measure is introduced to evaluate the importance of each leaf chunk in the tree, which in turn helps us to eliminate noise in a deep web page. In this measure, remove the surplus noise and duplicate chunk using three parameters such as hyperlink percentage, Noise score and cosine similarity. Finally, obtain the main chunk extraction process using three parameters such as Title word Relevancy, Keyword frequency based chunk selection, Position features and a set of keywords are extracted from those main chunks. Phase-2 Web Document Clustering In Phase-2 VDEC perform web document clustering using Fuzzy c-means clustering (FCM), the set of keywords were clustered for all deep web pages. Both the phases of the VDEC helps to extract the visual features of the web pages and supports on web page clustering for improvising information retrieval. The process activities are briefly described in the following section. DEFINITIONS OF TERMS USED IN VDEC APPROACH Definition (chunk): Consider a deep web page is segmented by blocks. These each block are known as chunk. For example the web page is represented as, , where the main chunk, . Definition (Hyperlink): A hyperlink has an anchor, which is the location within a document from which the hyperlink can be followed; the document having a hyperlink is called as its source document to web pages. Hyperlink percentage Where, à ¯Ã†â€™Ã‚   Number of Keywords in a chunk à ¯Ã†â€™Ã‚   Number of Link Keywords in a chunk Definition (Noise score): Noise score is defined as the ratio of the number of images in total number of chunks. Noise score, Where, à ¯Ã†â€™Ã‚   Number of images in a chunk à ¯Ã†â€™Ã‚   Total number of images Definition (Cosine similarity): Cosine similarity means calculating the similarity of two chunks. The inner product of the two vectors, i.e., the sum of the pairwise multiplied elements, is divided by the product of their vector lengths. Cosine Similarity, Where, , à ¯Ã†â€™Ã‚  Weight of keywords in, Definition (Position feature): Position features (PFs) that indicate the location of the data region on a deep web page. To compute the position feature score, the ratio is computed and then, the following equation is used to find the score for the chunk. (4) Where, à ¯Ã†â€™Ã‚   à ¯Ã†â€™Ã‚   Position features Definition (Title word relevancy): A web page title is the name or heading of a Web site or a Web page. If there is more number of title words in a certain block, then it means that the corresponding block is of more importance. Title word relevancy, Where, à ¯Ã†â€™Ã‚   Number of Title Keywords à ¯Ã†â€™Ã‚   Frequency of the title keyword in a chunk Definition (Keyword frequency): Keyword frequency is the number of times the keyword phrase appears on a deep Web page chunk relative to the total number of words on the deep web page. Keyword frequency based chunk selection, Where, à ¯Ã†â€™Ã‚   Frequency of top ten keywords à ¯Ã†â€™Ã‚   Number of keywords à ¯Ã†â€™Ã‚   Number of Top-K Keywords PHASE-1 – VISION BASED DEEP WEB DATA EXTRACTION In a web page, there are numerous immaterial components related to the descriptions of data objects. These items comprise an advertisement bar, product category, search panel, navigator bar, and copyright statement, etc. Generally, a web page is specified by a triple. is a finite set of objects or sub-web pages. All these objects are not overlapped. Each web page can be recursively viewed as a sub-web-page and has a subsidiary content structure. is a finite set of visual separators, such as horizontal separators and vertical separators. Every separator has a weight representing its visibility, and all the separators in the same have the same weight. is the relationship of every two blocks in , which is represented as:. In several web pages, there are normally more than one data object entwined together in a data region, which makes it complex to find the attributes for each page. Deep Web Page Extraction The Deep web is usually defined as the content on the Web not accessible through a search on general search engines. This content is sometimes also referred to as the hidden or invisible web. The Web is a complex entity that contains information from a variety of source types and includes an evolving mix of different file types and media. It is much more than static, self-contained Web pages. In our work, the deep web pages are collected from Complete Planet (www.completeplanet.com), which is currently the largest deep web repository with more than 70,000 entries of web databases. Chunk Segmentation Web pages are constructed not only main contents information like product information in shopping domain, job information in a job domain, but also advertisements bar, static content like navigation panels, copyright sections, etc. In many web pages, the main content information exists in the middle chunk and the rest of the page contains advertisements, navigation links, and privacy statements as noisy data. Removing these noises will help in improving the mining of the web and it’s called Chunk Segmenting Operation as shown in figure.5.2. Figure 5.2 Chunk Segmenting Operation To assign importance to a region in a web page (), we first need to segment a web page into a set of chunks. It extracts main content information and deep web clustering that is both fast and accurate. The two stages and its sub-steps are given as follows. Stage 1: Vision-based deep web data identification Deep web page extraction Chunk segmentation Noisy chunk Removal Extraction of main chunk using chunk weightage Stage 2: Web document clustering Clustering process using FCM Normally, a tag separated by many sub tags based on the content of the deep web page. If there is no tag in the sub tag, the last tag is consider as leaf node. The Chunk Splitting Process aims at cleaning the local noises by considering only the main content of a web page enclosed in div tag. The main contents are segmented into various chunks. The result of this process can be represented as follows: , Where, à ¯Ã†â€™Ã‚   A set of chunks in the deep web page à ¯Ã†â€™Ã‚   Number of chunks in a deep web page In Figure 5.1, we have taken an example of a tree sample which consists of main chunks and sub chunks. The main chunks are segmented into chunks C1, C2 and C3 using Chunk Splitting Operation and sub-chunks are segmented into . Noisy Chunk Removal A deep web page usually contains main content chunks and noise chunks. Only the main content chunks represent the informative part that most users are interested in. Although other chunks are helpful in enriching functionality and guiding browsing, they negatively affect such web mining tasks as web page clustering and classification by reducing the accuracy of mined results as well as speed of processing. Thus, these chunks are called noise chunks. Removing these chunks in our research work, we have concentrated on two parameters; they are Hyperlink Percentage and Noise score which is very significant. The main objective of removing noise from a Web Page is to improve the performance of the search engine. The representation of each parameter is as follows: Hyperlink Keyword – A hyperlink has an anchor, which is the location within a document from which the hyperlink can be followed; the document containing a hyperlink is known as its source document to web pages. Hyperlink Keywords are the keywords which are present in a chunk such that it directs to another page. If there are more links in a particular chunk then it means the corresponding chunk has less importance. The parameter Hyperlink Keyword Retrieval calculates the percentage of all the hyperlink keywords present in a chunk and is computed using the following equation. Hyperlink word Percentage, Where, à ¯Ã†â€™Ã‚   Number of Keywords in a chunk à ¯Ã†â€™Ã‚   Number of Link Keywords in a chunk Noise score – The information on Web page consists of both text and images (static pictures, flash, video, etc.). Many Internet sites draw income from third-party advertisements, usually in the form of images sprinkled throughout the site’s pages. In our work, the parameter Noise score calculates the percentage of all the images present in a chunk and is computed using the following equation. Noise score, Where, à ¯Ã†â€™Ã‚   Number of images in a chunk à ¯Ã†â€™Ã‚   Total number of images Duplicate Chunk Removal Using Cosine Similarity: Cosine Similarity Cosine similarity is one of the most popular similarity measure applied to text documents, such as in numerous information retrieval applications [7] and clustering too [8]. Here, duplication detection among the chunk is done with the help of cosine similarity. Given two chunks and, their cosine similarity is Cosine Similarity Where, , à ¯Ã†â€™Ã‚  Weight of keywords in, Extraction of Main Block Chunk Weightage for Sub-Chunk: In the previous step, we obtained a set of chunks after removing the noise chunks, and duplicate chunks present in a deep web page. Web page designers tend to organize their content in a reasonable way: giving prominence to important things and deemphasizing the unimportant parts with proper features such as position, size, color, word, image, link, etc. A chunk importance model is a function to map from features to importance for each chunk, and can be formalized as : . The preprocessing for computation is to extract essential keywords for the calculation of Chunk Importance. Many researchers have given importance to different information inside a webpage for instance location, position, occupied area, content, etc. In this research work, we have concentrated on the three parameters Title word relevancy, keyword frequency based chunk selection, and position features which are very significant. Each parameter has its own significance for calculating sub-chunk weightage. The following equation computes the sub-chunk weightage of all noiseless chunks. (1) Where à ¯Ã†â€™Ã‚   Constants For each noiseless chunk, we have to calculate these unknown parameters, and. The representation of each parameter is as follows: Title Keyword – Primarily, a web page title is the name or title of a Web site or a Web page. If there is more number of title words in a particular block then it means the corresponding block is of more importance. This parameter Title Keyword calculates the percentage of all the title keywords present in a block. It is computed using the following equation. Title word Relevancy; (2) Where, à ¯Ã†â€™Ã‚   Number of Title Keywords à ¯Ã†â€™Ã‚   Title word relevancy, à ¯Ã†â€™Ã‚   Frequency of the title keyword in a chunk. Keyword Frequency based chunk selection: Basically, Keyword frequency is the number of times the keyword phrase appears on a deep Web page chunk relative to the total number of words on the deep web page. In our work, the top-K keywords of each and every chunk were selected and then their frequencies were calculated. The parameter keyword frequency based chunk selection calculates for all sub-chunks and is computed using the following equation. Keyword Frequency based chunk selection (3) Where, à ¯Ã†â€™Ã‚   Frequency of top ten keywords à ¯Ã†â€™Ã‚   Keyword Frequency based chunk selection à ¯Ã†â€™Ã‚   Number of Top-K Keywords Position features (PFs): Generally, these data regions are always centered horizontally and for calculating, we need the ratio of the size of the data region to the size of the whole deep Web page instead of the actual size. In our experiments, the threshold of the ratio is set at 0.7, that is, if the ratio of the horizontally centered region is greater than or equal to 0.7, then the region is recognized as the data region. The parameter position features calculate the important sub chunk from all sub chunks and is computed using the following equation. (4) Where, à ¯Ã†â€™Ã‚   à ¯Ã†â€™Ã‚   Position features Thus, we have obtained the values of, and by substituting the above mentioned equation. By substituting the values of , and in eq.1, we obtain the sub-chunk weightage. Chunk Weightage for Main Chunk: We have obtained sub-chunk weightage of all noiseless chunks from the above process. Then, the main chunks weightage are selected from the following equation (5) Where,à ¯Ã†â€™Ã‚   Sub-chunk weightage of Main-chunk. à ¯Ã†â€™Ã‚   Constant, à ¯Ã†â€™Ã‚   Main chunk weightage. Thus, finally we obtain a set of important chunks and we extract the keywords from the above obtained important chunks for effective web document clustering mining. Algorithm-1 : Clustering Approach PHASE-2 – DEEP WEB DOCUMENT CLUSTERING USING FCM Let DB be a dataset of web documents, where the set of keywords is denoted by . Let X={x1, x2, †¦Ã¢â‚¬ ¦, xN} is the set of N web documents, where, xi={ xi1,xi2,†¦.,xin}. Each xij(i=1,†¦.,N;j=1,†¦.,n) corresponds to the frequency of keyword xi on web document. Fuzzy c-means [29] partitions set of web documents indimensional space into fuzzy clusters with cluster centers or centroids. The fuzzy clustering of keywords is described by a fuzzy matrix with n rows and c columns in which n is the number of keywords and c is the number of clusters. , the element in the row and column in, indicates the degree of association or membership function of the object with the cluster. The characters of are as follows: (6) (7) (8) The objective function of FCM algorithm is to minimize the Eq. (9): (9) Where (10) in which, m(m >1) is a scalar termed the weighting exponent and controls the fuzziness of the resulting clusters and dij is the Euclidian distance from key to the cluster center zip. The zj, centroid of the jth cluster, is obtained using Eq. (11) (11) The FCM algorithm is iterative and can be stated as in Algorithm-2. Algorithm-2 : Fuzzy c-means Approach Experimental Setup The experimental results of the proposed method for vision-based deep web data extraction for web document clustering are presented in this section. The proposed approach has been implemented in Java (jdk 1.6) and the experimentation is performed on a 3.0 GHz Pentium PC machine with 2 GB main memory. For experimentation, we have taken many deep web pages which contained all the noises such as Navigation bars, Panels and Frames, Page Headers and Footers, Copyright and Privacy Notices, Advertisements and Other Uninteresting Data. These pages are then applied to the proposed method for removing the different noises. The removal of noise blocks and extracting of useful content chunks are explained in this sub-section. Finally, extracting the useful con

the color purple Essay -- essays research papers

There are many racial components in this novel that are easy to point out. These take place in the American South and also in Africa. It starts with the way that all the black men and women are treated at the start of the book. The main character’s real father was a successful store owner who was black. This man was hanged for a reason that is known only as him being a successful black man. All the characters that we are introduced to in this book by Celie are exploited by the fact that they are black. Sophia is beat up and jailed for her refusal to want to work for a white women. Of course she stood up for herself and the white element tried to tell her where her place was. There is also an intra racial theme that starts at the beginning of the book that is hard to actually believe. But to me it would make sense after awhile, because if the people tell you something over and over you would start to believe and accept it. This is shown by the acceptance of what happen to Soph ia by her peers. Albert shows this with his denial that Celie could do anything well because she is a black, poor, ugly woman. If there was not any self disapproval among these people than that Albert’s black comment would not be prevalent. All the black characters in the book with the exception of Shug are poor and have a bad educational back round. It does not describe these characters as stupid just not well educated. This is inflicted by people selling them on how it is wrong to educate a black person. The feminism components are more main stream than the racial issues. The women at the start of the story are expected to cook, clean, and lay down when told to. They are beaten when they do not obey their husband or man. The men act as if Women are there to serve the man. Celie is forced to have sex with her step father and her husband because she is not strong enough to say no to Albert or her step father. â€Å"He just climb on top of me and do his business† says Celie. As if the women are there just to open her legs and let the man do what he wants to do. The real first theme of feminism is the act of Nettie to not give in and let Mr.__ have his way with her. In this act it showed him that he was not going to be able to take from a woman. That is a change because he had always gotten what he wanted because Celie was just too scared to stand up to him. As the story moves along Sophia is... ...making pants for women. A great deal of this novel looks at Africa and the narrative changes. I believe that this change was important to show that there was a parallel of the components, the fact that the tribes were exploited as well as the people in the American south. The village was trampled by the white man because they believe that they were superior and the Africans had no right to stay where they were. The novel was a very good depiction of what life was like for the African American men and women for this time. I believe that years of the treatment conditioned the peoples to act as they did out of habit. All it takes is one idea or one stand to change and that is what happens for each character in the book. I believe that Walker did a great job in capturing the time and I agree with her view on racism and feminism. I would love to believe that none of this could have happened but I know that this sort of social action was the just the spark that women and African Americans needed to start to level the playing field. There were so many brave people that are not fictional that went through the same things that should be applauded for trying in the first place. by j. katz

Present the way in which imprisonment is presented in The Bell Jar Essa

Present the way in which imprisonment is presented in The Bell Jar The bell jar is an inverted glass jar, generally used to display an object of scientific curiosity. Present the way in which imprisonment is presented in ‘The Bell Jar’ The bell jar is an inverted glass jar, generally used to display an object of scientific curiosity, contain a certain kind of gas, or maintain a vacuum. For Esther, the bell jar symbolizes madness. When gripped by insanity, she feels as if she is inside an airless jar that distorts her perspective on the world and prevents her from connecting with the people around her. At the end of the novel, the bell jar has lifted, but she can sense that it still hovers over her, waiting to drop at any moment. The narrative technique used in The Bell Jar is a first person narrative. Straight away we get the idea of imprisonment through elements of the unhappy narrative voice in the early chapters. The first sentence of Sylvia Plath's The Bell Jar alerts the reader to the conflicts that will be dealt with in this semi-autobiographical novel: "It was a queer, sultry summer, the summer they electrocuted the Rosenberg’s, and I didn't know what I was doing in New York." The speaker will tell us in the next few sentences that she is "stupid" and that she feels "sick," and that she is preoccupied with death. Like Holden Caulfield in Catcher in the Rye, this young, college age, girl-woman is experiencing an adolescent crisis. When Esther Greenwood tells us in the first sentence that this is "the summer they electrocuted the Rosenberg’s," we get a picture not only of that summer's being nauseating, sultry, and death-oriented, but that this young girl's attitudes and life experiences are ... ...e Plath uses characters such as buddy Willard, using a clever writing technique to show his relationship with others, how people viewed him, his actions and physical description. Through Buddy we can have a better understanding of Esther’s situation. Plath uses the technique of flashback for suspense and to delay the plot. A lot of similes and metaphors are used to contribute to imprisonment. For example similes reflecting the 1950’s ‘yellow as cinnamon’. Overall, I think that Plath is trying to convey the idea that women were being placed in a constricted role in society live as if in a bell jar, able to see the outside world of exciting work and self-determined men, but unable to live it. People suffering from emotional illness are also living as if under a bell jar, isolated from others and unable to escape the distortions of their view of the world.

Tuesdays with Morrie :: Free Essay Writer

Tuesdays with Morrie At the conclusion of the story there is Morrie slowly but surely deteriorating. At this point, he has finally â€Å"gotten† to Mitch and now Mitch is starting to show some emotions. One section in this portion of the book that really made me happy when reading it was the fact that Mitch was able to get in touch with his brother, tell him how he truly feels and how much he values their relationship and so they develop another one between the two before it’s too late. Morrie’s lessons are extremely important to everyone that he comes into contact with; he even brought out the best in Mitch’s wife Janine when she came to see him. The relationship that Morrie and Ted Koppel had developed in the three visits shows that anyone that he comes into contact with has no choice but to become attached to him. Morrie’s help became so bad in the last 3 sections or so to the point that he could not get out of the bed, Mitch had never seen him like this becaus e he was not one to lay around in the bed all day. His worse nightmare had happened, the disease had attacked his lungs and there was nothing else that could be done, a treatment had been developed but it didn’t cure the disease only prolonged it and Morrie was too far along for that. When Morrie died at the end of the story he was in the room by himself, he took his last breath when the family member that was holding vigil at his bedside walked to the kitchen. He had a private funeral for just close family and friends and Mitch vowed to keep their traditions of Tuesdays going but instead he would do all the talking and Morrie just listen. This has been the best book that I have read in a long time. It was filled with so many lessons that we as a society ignore.

Pharmaceutical Industry and E. Merck Ag

Historical background of the business Today Merck & Co, Inc. is one of the most recognizable companies in the pharmaceutical industry. When asked about Merck, most people think that it is and always has been a US company. However, the company’s history can be traced all the way back to the 1600’s where it was started in Darmstadt, Germany. Friedrich Jacob Merck purchased a local store in 1668 where he prepared and sold medicines. The store was called â€Å"At the sign of the Angels† and would remain in the Merck family for many generations (Merck & co. , 2000). In 1827, Heinrich Emmanuel Merck and renamed E.MERCK AG transformed the store into a drug manufacturer. The pharmacy was so successful that by 1855 E. Merck AG was selling medications worldwide. It was at this time that Merck decided to send a company officer to the United States to set up a sales office. Once in the U. S. in 1899, Heinrich’s grandson George Merck bought one hundred and fifty acres in Rahway, New Jersey. A couple of years later, in 1903, Merck started production in its new U. S. headquarters. By this time Merck was not just producing drugs, it was also starting to produce different types of chemicals and there was also a research lab.When the United States entered World War I in 1917, George Merck, fearing that Germany would win the war and take over his company, sold all of his stock to a US company named Alien Property Custodian (Merck & Co. , 2000). This ended all of Merck’s ties to Germany. After the war, George Merck regained a controlling share of the company in 1919 and from that day forward Merck has always been a publicly owned company. George Merck continued to grow the company until his death in 1926 at which time his son, George W. Merck took over. In 1926, George W.Merck decided to merge the company with Powers-Weightman-Rosengarten, which was a Philadelphia, based pharmaceutical company. In 1927 the company was officially incorporated and renamed Merck & Co. Inc. This merger gave George W. Merck the capital he needed to recruit new chemists and biologists, which lead to the discovery of vitamin B12. Vitamin B12 was a huge success, but because the war had been over for several years, new foreign companies were continually underselling Merck. With no new products in sight, George W. Merck decided to merge with a Baltimore company by the name of Sharp & Dohme, Inc.This merger was believed to have saved Merck from going under; it gave Merck new marketing facilities and a new distribution network, which it desperately needed. By the time George W. Merck died in 1957, the company had hit the one hundred million dollar mark. Not only was the dollar mark significant, George’s death marked the last time a Merck family member would ever be in control. From the 60’s on, Merck continued to raise its market share taking advantage of its research and development, which continually produced new and popular drugs every year.Today Merck employs over fifty five thousand people and produces some of the most well known pharmaceutical products on the market. With profits totaling a little fewer than six billion dollars and annual sales of over twelve and half billion dollars, Merck is considered one of the best pharmaceutical companies in the world. Products Throughout the years, Merck has made itself a reputation for developing high quality products that consumers know will work. The drugs are developed to help with all different types of problems.Some medicines are used for every day symptoms like a stuffed up nose and some are used for more serious illnesses like the treatment of HIV. Since Merck & Co. , Inc. was founded; it has always made a point to have an above average research and development program so that it could appeal to a wide variety of consumers no matter what symptoms they were trying to cure. Some of the first products ever distributed by Merck in the 1820’s were morphine, co deine and cocaine. These three products allowed Merck enough revenue to begin research on other types of products.In 1933 Merck scientists discovered vitamin B12 which was, at the time, used as a therapeutic drug. The sales from B12 alone were enough to carry Merck into the next decade. Although Merck scientists discovered cortisone, which is a steroid, and streptomycin, which is used to treat tuberculosis, the 1940’s, 50’s and 60’s were fairly slow periods for Merck. Other products such as Aldomet, which is used to treat depression, Indocin and Clinoril which are anti-inflammatory drugs, were developed but none of them had the impact on revenue that Merck was used to.It was not until the mid to late 70’s that Merck came out with some new products that really connected with consumers. It was at this time that Timoptic and Enalapril were invented. Timoptic is a hepatitis vaccine that helps with the treatment of glaucoma and Enalapril is a high blood pressu re medication. Sales from these two drugs were well over a half a billion dollars by the early 1980’s. Things only got better for Merck from the 1980’s through 2000. During this time Merck produced over twenty new drugs.Some of the more popular drugs include Cosopt, used in the treatment of glaucoma, Propecia, which is used to treat hair loss, Maxalt, which is used for migraine headaches, and Singulair, which treats cases of asthma. Although all of these medications worked out very well for Merck’s profit, there were three drugs that stood above the rest. Vasotec was a treatment for congestive heart failure and Merck’s first billion dollar a year drug. That was followed by Vioxx which is a pain medication used to treat arthritis and also a billion dollar a year seller. The most popular drug Merck ever produced was Zocor.Zocor is a cholesterol-fighting drug that was introduced in 1992. Not only was zocor a multi-billion dollar a year drug, it was one of th e most successful selling pharmaceutical drugs ever (Merck & Co. , 2000). Zocor accounted for over four billion dollars in worldwide sales in 2004 alone. With products like these and a continued dedication to research and development, Merck will be a major player in the pharmaceutical industry for many years to come. Company Locations Merck and its subsidiaries have locations all over the world. Their main headquarters is currently located in Whitehouse Station, New Jersey.Merck takes pride in being a global healthcare leader. According to their website they currently have 83,000 employees worldwide (Merck. com). In 2009, Merck merged with competitor Shering-Plough, which extended Merck’s reach into the global economy. According to Muse (2011), Merck has over 75 locations, â€Å"Drawing from its locations in 77 countries, Merck’s worldwide sales for 2009 were $27. 4 billion (Muse p. 251). † These locations stretch across the continental United States from New Je rsey to San Francisco. The worldwide locations include factories in Europe, the Middle East, Africa, and Japan.Merck’s revenues continue to climb with their global growth. The revenues recorded in various regions by Merck in 2012 include, â€Å" |2012 Revenues |United States | |(By Geographic Region) |$20. 4 billion | | | | | |Europe, Middle East and Africa | | |$13. billion | | | | | |Japan | | |$5. 1 billion | | | | | |Other | | |$8. billion (Merck. com). † | | | | Merck is seen as a leader on the stage of global expansion. It is one of the largest pharmaceutical companies in the world. Merck continues to grow and expand its influence in an effort to provide their vaccines and medicines across the globe. Their recent merger will allow them to test markets that they have not had experience in before, and help increase their profits globally.Style of International Business Merck has been on the forefront of International Business and is one of the leaders at adapt ing to new employees in diverse geographic locations. The company has maintained a policy of progressiveness in their workplace. According to Muse (2011) Merck is one of the leaders in this field. They have been ranked among the Top 50 Companies for Diversity and the 100 Best Corporate Citizens List (Muse p. 251). † Merck makes diversity one of their top priorities and it is well documented on their website. They have created a voice for the different diverse peoples within their company.It is a new way to maintain communication with the feelings and thoughts of various groups in different regions throughout the world. Merck calls these Global Constituency Groups. According to their website, â€Å"We've taken an innovative, global approach to our diversity strategy through the creation of Global Constituency Groups. These groups represent the diverse constituencies in our company, our customers and society, in general. The members represent different geographies, cultures and areas of expertise. Together they reflect Merck employees and customers globally†. Merck. com) With this process, Merck is able to keep up with the problems and successes within the different constituencies throughout the company. Merck’s plan to achieve diversity within their company begins from the leadership positions. Filling these positions with people mindful of diversity has allowed the company to continue to keep its place among the most diverse companies in the world. According to Merck, â€Å"Diversity and inclusion are integrated into our leadership model, and are considered an essential leadership skill for all of our employees (Merck. com). Merck preaches this diversity not only to their employees, but their suppliers as well. â€Å"At Merck, we believe that having a diverse supplier base helps us better understand and anticipate the needs of the people we serve (Merck. com). † This creates a positive culture throughout the company of acceptance an d tolerance towards others. It is a progressive policy that allows Merck to continue to flourish and it is a model style of International Business. Strategic Alliances Merck has made many strategic alliances throughout the years to help improve their products or supply them to a wider range of people.In the late 80’s Merck made an alliance with one of the biggest companies in the United States, Johnson & Johnson. According to the International Directory of Company Histories (2000), â€Å"In 1989 Merck joined with Johnson & Johnson in a venture to develop over-the-counter (OTC) versions of Merck’s prescription medications, initially for the U. S. market, later expanded to Europe and Canada (encyclopedia. com)†. This helped Merck products become more easily available to consumers throughout the world. At the time this alliance was hailed as a blockbuster deal that would create growth for both companies.This deal lasted over twenty years and was very profitable for both parties. When Merck sold their stake in the deal in 2011, they received $175 million for it. The largest alliance Merck has made recently is the acquisition, or reverse merger, of their rival Schering-Plough. The $40 billion deal was made in an effort to keep up with other companies in the pharmaceutical market, especially Pfizer. According to Singer (2009), â€Å"The merger would join pharmaceutical companies that had combined sales of $46. 9 billion last year (p. 1). † This alliance expanded Merck globally and allowed it to tap into Schering-Plough’s resources.These resources ranged from new drugs for Merck to market, to a bigger pipeline to promote their own drugs. According to Singer (2009), â€Å"The merger gives it access to successful brand-name Schering products with much longer patents, like the prescription allergy spray Nasonex. And Merck could capitalize on Schering’s investments in promising biotechnology drugs (Singer p. 1 ). † This al liance helped Merck continue to be a formidable competitor in the global pharmaceutical market. With this deal happening only a few short years ago, Merck continues to grow and utilize its new resources in the market today.Exports Merck’s exports consist of various types of pharmaceuticals. Some of their most profitable exports include Singulair, Fosamax, Nasonex, and Vytorin. Singulair is used to treat seasonal allergies like other drugs such as Claritin and Allegra. It can also be used to prevent asthma attacks. It has been very profitable for Merck in the past. Yet, sales began to dramatically fall when media reports about the disturbing side effects of Singulair began to surface. The worst of these side effects included depression and suicidal thoughts.Still, even in spite of Singulair’s profit drop, Merck continues to make large amounts of money off of the export. Nasonex and Vytorin are two products that were a result of the Merck and Schering-Plough merger. Naso nex is a nasal spray used to treat seasonal allergies in adults and children. It has proved to be a positive part of the merger, becoming one of Merck’s most profitable products. Vytorin was already part of a joint effort between Merck and Schering-Plough even before the merger. Vytorin is a combination of ezetimibe and simvastatin used to treat cholesterol levels.They created and marketed the product together. After the merger, Merck continued to sell and market Vytorin. Fosamax is another popular export of the Merck Company. It is used to treat osteoporosis and other bone diseases. Fosamax was previously one of Merck’s best selling drugs. Yet, because of patent problems, they have lost large amount of money. According to Singer (2009) â€Å"Merck’s former blockbuster bone drug Fosamax has gone generic, and in a few years the same thing will happen to its best-selling allergy and asthma drug Singulair (pg. 1 ). † These exports have been Merck’s ma in products in the past.In the future, with their recent merger, they should be able to develop new products that can help them rebound from the losses they took from products like Fosamax and Singulair. Transportation In order to effectively and efficiently deliver their products throughout the world, Merck has contracted UPS to deliver them. As of June 2011, the joint venture known as MSD has announced that it would include and take care of Merck’s logistics and distribution around the world, which till now only managed Merck’s distribution, warehousing and transportation in North America (Berman, 2011).According to Willie A. Deese, executive vice president and president, Merck Manufacturing Division,â€Å" This expanded agreement with UPS allows us to focus on our core business as a global healthcare leader that looks for innovative ways to bring our medicines and vaccines to patients in emerging markets and markets around the world† (businesswire, 2011). The collaboration, which began in early 2003 with UPS just taking care of the transportation and delivery of products over time, has extended to North American distribution, warehousing and multi-modal transportation services (businesswire, 2011).Merck now entrusted UPS with taking care of their logistics in countries like China, Brazil as well as Latin America among others. UPS also stated that it would establish proper facilities in order to store goods and vaccines so in order to ensure quicker and efficient delivery system (Berman, 2011). Merck believes that this extended partnership with UPS would result in being cost effective in the long run. Although Merck does rely on other logistic companies as well, but they rely more heavily on UPS and this current agreement will only further increase the company’s trust in the logistics firm (businesswire, 2011).Ethical Standards The code of ethics from Merck’s website (2013) states: Being a good corporate citizen means that we comply with all applicable laws, rules and regulations. Also, we serve our society, from the local communities in which we operate to the national and international levels, by supporting a number of programs, including those that improve health and promote environmental sustainability. All of our activities are guided by our corporate responsibility principle of â€Å"Helping the World Be Well†. (p. 1) Ethical Violations Merck & Co. ave developed some great products that have helped many people. They have even done some amazing humanitarian work that follows their mission of their code of ethics, which is to help the people of this world be as healthy as they can. For example, After World War II, many people who were living in Japan could not afford the Merck developed drug streptomycin (Miller & Goldman, 2003). Streptomycin was the first drug to fight tuberculosis. Merck decided to sell streptomycin at a much lower cost in Japan so it could be distributed to those who nee ded it and could not afford it at market value.Merck is also one of the nation’s largest donors to UNICEF. One of the ways that Merck has partnered with UNICEF is by donating a drug called Mectizan. Mectizan is a drug that Merck has developed to fight river blindness, and Merck has teamed up with UNICEF in order to distribute Mectizan to anyone who needs it (Unicef, 2013). But the business strategies for Merck have not always been as ethically sound as it may appear. On September 30th 2004 the drug that Merck had created to treat arthritis and severe pain, Vioxx, was pulled off the shelves for good.The reason behind shutting down this drug was that it was found to have caused serious illnesses after long term use, including heart attacks and strokes (Kay, 2004). Vioxx was withdrawn only five years after being introduced, but in that short time had effected many, in those five years there had been over eighty million prescriptions for Vioxx (Kay, 2004). Dr David Graham, the as sociate director for science and medicine at the Office of Drug Safety, estimates that Vioxx caused between 88,000 and 139,000 heart attacks, of which thirty to forty percent have most likely died (Kay, 2004).But did Merck know of this threat before they started to market the drug? Before Merck released Vioxx in 1999 their own scientist conducted tests on Vioxx while developing it. In 1997 these scientist did a study and found that patients who were being tested on were six times more likely to have heart complications when using Vioxx compared to other arthritis drugs. But this study was never released and the data was never sent to the FDA (Culp & Isobel, 2007).Scientist also completed a VIGOR (Vioxx Gastrointestinal Outcomes Research) test on the drug and found evidence that people who take Vioxx had a five times higher chance of having a heart attack (Cahana & Mauron, 2006). In 2001 Merck scientist had another test called â€Å"meta-analysis†. The meta-analysis tested 20, 000 patients, and again showed that these patients were twice as likely to have a heart attack while taking Vioxx compared to other drugs (Culp & Isobel, 2007). Not only did Merck know about these risks and kept the results to themselves, they also trained their sales people on how to dodge the subject.In order to train the sales force who were going to be selling Vioxx to doctors, Merck developed a card game called dodgeball. The purpose of this game was to teach the sales force different ways to dodge questions asked by doctors about the effects Vioxx has on the heart (Daily, 2005). This again proves that Merck knew of these risks caused by taking Vioxx, but was trying to make sure that information was kept in house. Another instance where Merck lacked good ethical decision making is when they decided to pay Elsevier to publish a magazine for them. Elsevier is a publishing company that focuses mainly on medical and scientific literature.Merck’s marketing team decided to pay Elsevier to publish a journal called The Australiasian Journal of Bone & Joint Medicine. This journal was made to look like any other peer-reviewed medical journal but it was far from it. Merck’s marketing department handpicked the articles that they wanted to put in this journal, with the purpose of trying to control what articles were chosen to be in the journal. They took advantage of this situation by picking articles that favored Merck products and disguising this marketing scheme as a peer review journal (Grant, 2009).For instance in the second issue twenty one of the twenty nine articles spoke about Merck’s products in a favorable way, nine of them positively talking about Vioxx (Grant, 2009). Merck also had an ethical downfall when management decided to change the prices of their product. Not only was Merck paying doctors to prescribe Merck medicine when patients were in the hospital, Merck also started to give hospitals a ninety two percent discount on their medicine; with the idea that after the patient was discharged they would want to stay on the same medicine (Merck to pay whistleblower, 2008).The insurance company would pay full price for the drugs after the patient was discharged and that is where Merck would bring in their profit. An employee within Merck saw what was going on and didn’t approve. A lawsuit quickly followed and Merck ended up paying $671 million, including sixty eight million dollars to the whistleblower (Merck to pay whistleblower, 2008). Even after settling Merck did not think they were in the wrong with this pricing, as Merck to pay whistleblower (2008) reported Merck making a statement saying they â€Å"stands by its pricing strategies but is keen to resolve the dispute† (p. 2). Unfortunately for Merck, Vioxx isn’t the only drug that has caused people to question Merck’s ethical decision making when it comes to their customers. As noted above, Merck released a drug called Propecia t o the public that helped men with baldness. The problem with Propecia is that men are starting to see a great increase in sexual problems. Merck says that only one out of fifty men will see significant sexual side effects, and those side effects will disappear after you stop taking Propecia (Thornton, 2011). But that doesn’t seem to be the case.A recent study by Micheal Irving showed that ninety percent of his test patients still showed signs of sexual problems forty months after being off of Propecia (Thornton, 2011). This is where ethics will hurt Merck the most. Not only have there been hundreds of millions of dollars in fines and settlements that will be paid out, but if Merck continues to keep making unethical managerial decisions, Merck will lose the trust of their customers. Even though there is no evidence yet that Merck knew that Propecia would harm people after they stopped taking the drug, it’s hard not to think of how the Merck management decided to handle Vioxx.The financial hit is a big blow that will slow present and future projects, but money is a lot easier to gain back than trust. References Berman, J. (2011, June). UPS and Merck extend relationship with a global supply chain focus. Retrieved February 2013, from http://www. logisticsmgmt. com/article/ups_and_merck_extend_relationship_witha_ global_supply_chain_focus/ businesswire. (2011, June). UPS and Merck Expand Their Distribution and Logistics Agreement. Retrieved February 2013, from businesswire. com: http://www. businesswire. com/news/home/20110628005271/en/UPS-Merck-Expand-Distribution-Logistics-AgreementCahana, A. , & Mauron, A. (2006). The story of Vioxx—no pain and a lot of gain: ethical concerns regarding conduct of the pharmaceutical industry. Journal of anesthesia,  20(4), 348-351. doi:10. 1007/s00540-006-0432-7 Culp, D. R. , & Isobel, B. (2007, August 6). Merck and the Vioxx       debacle. Retrieved February 13, 2013 from St. Johns University,       Web site: http://www. stjohns. edu/media/3/2c0778b7593f4a178b60354abc80bad8. pdf Grant, B. (2009, April 30). Merck published fake journal. Retrieved Febuary 12, 2013 from, Web site: http://www. the-scientist. om/? articles. view/articleNo/27376/title/Merck- published-fake- journal/ Daily, M. (2005, July 18). Merck used ‘dodge ball’ on Vioxx       questions-lawyer. Retrieved February 12, 2013 from, Web site:       http://www. redorbit. com/news/general/178738/ Kay, J. ( 2004, November 22). The Vioxx scandal: Damning senate       testimony reveals drug company, government complicity. Retrieved 2013, February 9 from , Web site: http://www. wsws. org/en/articles/2004/11/viox-n22. html Merck & Co. , Inc. International Directory of Company Histories. 2000.Retrieved February 19, 2013 from Encyclopedia. com:  http://www. encyclopedia. com/doc/1G2-2843800076. html Merck Sharp & Dohme Corp. , a subsidiary of  Merck & Co. , Inc. (2009-2013). Retrieved February 18 , 2013, from http://www. merck. com/index. html Merck to pay whistleblower. (2008). TCE: The Chemical Engineer, (801), 12. Miller, C. , & Goldman, K. (2003, October, 23). Merck, aids, and       Africa. Retrieved February 2, 2013 from New York University,       Leonard N. Stern School of Business Web site: http://pages. stern. nyu. edu/~lcabral/teaching/aids. pdf Muse, L.A. (2011). Flexibility implementation to a global workforce: a case study of Merck and Company, Inc. Community, Work & Family,  14(2), 249-256. Singer, N. (March 9, 2009). Merck to Buy Schering-Plough for $41. 1 Billion. The New York Times, Retrieved from http://www. nytimes. com/2009/03/10/business/10drug. html? _r=0 February 19, 2013. Thornton, J. (2011). A Hair-Raising Side Effect. Men's Health (10544836), 26(10), 102-105. Unicef (2013). Merck & co. , inc. Retrieved January 12, 2013 from, Partners Web site       http://www. unicefusa. org/partners/corporate/merck. html Pharmaceutical Industry and E. Merck Ag Historical background of the business Today Merck & Co, Inc. is one of the most recognizable companies in the pharmaceutical industry. When asked about Merck, most people think that it is and always has been a US company. However, the company’s history can be traced all the way back to the 1600’s where it was started in Darmstadt, Germany. Friedrich Jacob Merck purchased a local store in 1668 where he prepared and sold medicines. The store was called â€Å"At the sign of the Angels† and would remain in the Merck family for many generations (Merck & co. , 2000). In 1827, Heinrich Emmanuel Merck and renamed E.MERCK AG transformed the store into a drug manufacturer. The pharmacy was so successful that by 1855 E. Merck AG was selling medications worldwide. It was at this time that Merck decided to send a company officer to the United States to set up a sales office. Once in the U. S. in 1899, Heinrich’s grandson George Merck bought one hundred and fifty acres in Rahway, New Jersey. A couple of years later, in 1903, Merck started production in its new U. S. headquarters. By this time Merck was not just producing drugs, it was also starting to produce different types of chemicals and there was also a research lab.When the United States entered World War I in 1917, George Merck, fearing that Germany would win the war and take over his company, sold all of his stock to a US company named Alien Property Custodian (Merck & Co. , 2000). This ended all of Merck’s ties to Germany. After the war, George Merck regained a controlling share of the company in 1919 and from that day forward Merck has always been a publicly owned company. George Merck continued to grow the company until his death in 1926 at which time his son, George W. Merck took over. In 1926, George W.Merck decided to merge the company with Powers-Weightman-Rosengarten, which was a Philadelphia, based pharmaceutical company. In 1927 the company was officially incorporated and renamed Merck & Co. Inc. This merger gave George W. Merck the capital he needed to recruit new chemists and biologists, which lead to the discovery of vitamin B12. Vitamin B12 was a huge success, but because the war had been over for several years, new foreign companies were continually underselling Merck. With no new products in sight, George W. Merck decided to merge with a Baltimore company by the name of Sharp & Dohme, Inc.This merger was believed to have saved Merck from going under; it gave Merck new marketing facilities and a new distribution network, which it desperately needed. By the time George W. Merck died in 1957, the company had hit the one hundred million dollar mark. Not only was the dollar mark significant, George’s death marked the last time a Merck family member would ever be in control. From the 60’s on, Merck continued to raise its market share taking advantage of its research and development, which continually produced new and popular drugs every year.Today Merck employs over fifty five thousand people and produces some of the most well known pharmaceutical products on the market. With profits totaling a little fewer than six billion dollars and annual sales of over twelve and half billion dollars, Merck is considered one of the best pharmaceutical companies in the world. Products Throughout the years, Merck has made itself a reputation for developing high quality products that consumers know will work. The drugs are developed to help with all different types of problems.Some medicines are used for every day symptoms like a stuffed up nose and some are used for more serious illnesses like the treatment of HIV. Since Merck & Co. , Inc. was founded; it has always made a point to have an above average research and development program so that it could appeal to a wide variety of consumers no matter what symptoms they were trying to cure. Some of the first products ever distributed by Merck in the 1820’s were morphine, co deine and cocaine. These three products allowed Merck enough revenue to begin research on other types of products.In 1933 Merck scientists discovered vitamin B12 which was, at the time, used as a therapeutic drug. The sales from B12 alone were enough to carry Merck into the next decade. Although Merck scientists discovered cortisone, which is a steroid, and streptomycin, which is used to treat tuberculosis, the 1940’s, 50’s and 60’s were fairly slow periods for Merck. Other products such as Aldomet, which is used to treat depression, Indocin and Clinoril which are anti-inflammatory drugs, were developed but none of them had the impact on revenue that Merck was used to.It was not until the mid to late 70’s that Merck came out with some new products that really connected with consumers. It was at this time that Timoptic and Enalapril were invented. Timoptic is a hepatitis vaccine that helps with the treatment of glaucoma and Enalapril is a high blood pressu re medication. Sales from these two drugs were well over a half a billion dollars by the early 1980’s. Things only got better for Merck from the 1980’s through 2000. During this time Merck produced over twenty new drugs.Some of the more popular drugs include Cosopt, used in the treatment of glaucoma, Propecia, which is used to treat hair loss, Maxalt, which is used for migraine headaches, and Singulair, which treats cases of asthma. Although all of these medications worked out very well for Merck’s profit, there were three drugs that stood above the rest. Vasotec was a treatment for congestive heart failure and Merck’s first billion dollar a year drug. That was followed by Vioxx which is a pain medication used to treat arthritis and also a billion dollar a year seller. The most popular drug Merck ever produced was Zocor.Zocor is a cholesterol-fighting drug that was introduced in 1992. Not only was zocor a multi-billion dollar a year drug, it was one of th e most successful selling pharmaceutical drugs ever (Merck & Co. , 2000). Zocor accounted for over four billion dollars in worldwide sales in 2004 alone. With products like these and a continued dedication to research and development, Merck will be a major player in the pharmaceutical industry for many years to come. Company Locations Merck and its subsidiaries have locations all over the world. Their main headquarters is currently located in Whitehouse Station, New Jersey.Merck takes pride in being a global healthcare leader. According to their website they currently have 83,000 employees worldwide (Merck. com). In 2009, Merck merged with competitor Shering-Plough, which extended Merck’s reach into the global economy. According to Muse (2011), Merck has over 75 locations, â€Å"Drawing from its locations in 77 countries, Merck’s worldwide sales for 2009 were $27. 4 billion (Muse p. 251). † These locations stretch across the continental United States from New Je rsey to San Francisco. The worldwide locations include factories in Europe, the Middle East, Africa, and Japan.Merck’s revenues continue to climb with their global growth. The revenues recorded in various regions by Merck in 2012 include, â€Å" |2012 Revenues |United States | |(By Geographic Region) |$20. 4 billion | | | | | |Europe, Middle East and Africa | | |$13. billion | | | | | |Japan | | |$5. 1 billion | | | | | |Other | | |$8. billion (Merck. com). † | | | | Merck is seen as a leader on the stage of global expansion. It is one of the largest pharmaceutical companies in the world. Merck continues to grow and expand its influence in an effort to provide their vaccines and medicines across the globe. Their recent merger will allow them to test markets that they have not had experience in before, and help increase their profits globally.Style of International Business Merck has been on the forefront of International Business and is one of the leaders at adapt ing to new employees in diverse geographic locations. The company has maintained a policy of progressiveness in their workplace. According to Muse (2011) Merck is one of the leaders in this field. They have been ranked among the Top 50 Companies for Diversity and the 100 Best Corporate Citizens List (Muse p. 251). † Merck makes diversity one of their top priorities and it is well documented on their website. They have created a voice for the different diverse peoples within their company.It is a new way to maintain communication with the feelings and thoughts of various groups in different regions throughout the world. Merck calls these Global Constituency Groups. According to their website, â€Å"We've taken an innovative, global approach to our diversity strategy through the creation of Global Constituency Groups. These groups represent the diverse constituencies in our company, our customers and society, in general. The members represent different geographies, cultures and areas of expertise. Together they reflect Merck employees and customers globally†. Merck. com) With this process, Merck is able to keep up with the problems and successes within the different constituencies throughout the company. Merck’s plan to achieve diversity within their company begins from the leadership positions. Filling these positions with people mindful of diversity has allowed the company to continue to keep its place among the most diverse companies in the world. According to Merck, â€Å"Diversity and inclusion are integrated into our leadership model, and are considered an essential leadership skill for all of our employees (Merck. com). Merck preaches this diversity not only to their employees, but their suppliers as well. â€Å"At Merck, we believe that having a diverse supplier base helps us better understand and anticipate the needs of the people we serve (Merck. com). † This creates a positive culture throughout the company of acceptance an d tolerance towards others. It is a progressive policy that allows Merck to continue to flourish and it is a model style of International Business. Strategic Alliances Merck has made many strategic alliances throughout the years to help improve their products or supply them to a wider range of people.In the late 80’s Merck made an alliance with one of the biggest companies in the United States, Johnson & Johnson. According to the International Directory of Company Histories (2000), â€Å"In 1989 Merck joined with Johnson & Johnson in a venture to develop over-the-counter (OTC) versions of Merck’s prescription medications, initially for the U. S. market, later expanded to Europe and Canada (encyclopedia. com)†. This helped Merck products become more easily available to consumers throughout the world. At the time this alliance was hailed as a blockbuster deal that would create growth for both companies.This deal lasted over twenty years and was very profitable for both parties. When Merck sold their stake in the deal in 2011, they received $175 million for it. The largest alliance Merck has made recently is the acquisition, or reverse merger, of their rival Schering-Plough. The $40 billion deal was made in an effort to keep up with other companies in the pharmaceutical market, especially Pfizer. According to Singer (2009), â€Å"The merger would join pharmaceutical companies that had combined sales of $46. 9 billion last year (p. 1). † This alliance expanded Merck globally and allowed it to tap into Schering-Plough’s resources.These resources ranged from new drugs for Merck to market, to a bigger pipeline to promote their own drugs. According to Singer (2009), â€Å"The merger gives it access to successful brand-name Schering products with much longer patents, like the prescription allergy spray Nasonex. And Merck could capitalize on Schering’s investments in promising biotechnology drugs (Singer p. 1 ). † This al liance helped Merck continue to be a formidable competitor in the global pharmaceutical market. With this deal happening only a few short years ago, Merck continues to grow and utilize its new resources in the market today.Exports Merck’s exports consist of various types of pharmaceuticals. Some of their most profitable exports include Singulair, Fosamax, Nasonex, and Vytorin. Singulair is used to treat seasonal allergies like other drugs such as Claritin and Allegra. It can also be used to prevent asthma attacks. It has been very profitable for Merck in the past. Yet, sales began to dramatically fall when media reports about the disturbing side effects of Singulair began to surface. The worst of these side effects included depression and suicidal thoughts.Still, even in spite of Singulair’s profit drop, Merck continues to make large amounts of money off of the export. Nasonex and Vytorin are two products that were a result of the Merck and Schering-Plough merger. Naso nex is a nasal spray used to treat seasonal allergies in adults and children. It has proved to be a positive part of the merger, becoming one of Merck’s most profitable products. Vytorin was already part of a joint effort between Merck and Schering-Plough even before the merger. Vytorin is a combination of ezetimibe and simvastatin used to treat cholesterol levels.They created and marketed the product together. After the merger, Merck continued to sell and market Vytorin. Fosamax is another popular export of the Merck Company. It is used to treat osteoporosis and other bone diseases. Fosamax was previously one of Merck’s best selling drugs. Yet, because of patent problems, they have lost large amount of money. According to Singer (2009) â€Å"Merck’s former blockbuster bone drug Fosamax has gone generic, and in a few years the same thing will happen to its best-selling allergy and asthma drug Singulair (pg. 1 ). † These exports have been Merck’s ma in products in the past.In the future, with their recent merger, they should be able to develop new products that can help them rebound from the losses they took from products like Fosamax and Singulair. Transportation In order to effectively and efficiently deliver their products throughout the world, Merck has contracted UPS to deliver them. As of June 2011, the joint venture known as MSD has announced that it would include and take care of Merck’s logistics and distribution around the world, which till now only managed Merck’s distribution, warehousing and transportation in North America (Berman, 2011).According to Willie A. Deese, executive vice president and president, Merck Manufacturing Division,â€Å" This expanded agreement with UPS allows us to focus on our core business as a global healthcare leader that looks for innovative ways to bring our medicines and vaccines to patients in emerging markets and markets around the world† (businesswire, 2011). The collaboration, which began in early 2003 with UPS just taking care of the transportation and delivery of products over time, has extended to North American distribution, warehousing and multi-modal transportation services (businesswire, 2011).Merck now entrusted UPS with taking care of their logistics in countries like China, Brazil as well as Latin America among others. UPS also stated that it would establish proper facilities in order to store goods and vaccines so in order to ensure quicker and efficient delivery system (Berman, 2011). Merck believes that this extended partnership with UPS would result in being cost effective in the long run. Although Merck does rely on other logistic companies as well, but they rely more heavily on UPS and this current agreement will only further increase the company’s trust in the logistics firm (businesswire, 2011).Ethical Standards The code of ethics from Merck’s website (2013) states: Being a good corporate citizen means that we comply with all applicable laws, rules and regulations. Also, we serve our society, from the local communities in which we operate to the national and international levels, by supporting a number of programs, including those that improve health and promote environmental sustainability. All of our activities are guided by our corporate responsibility principle of â€Å"Helping the World Be Well†. (p. 1) Ethical Violations Merck & Co. ave developed some great products that have helped many people. They have even done some amazing humanitarian work that follows their mission of their code of ethics, which is to help the people of this world be as healthy as they can. For example, After World War II, many people who were living in Japan could not afford the Merck developed drug streptomycin (Miller & Goldman, 2003). Streptomycin was the first drug to fight tuberculosis. Merck decided to sell streptomycin at a much lower cost in Japan so it could be distributed to those who nee ded it and could not afford it at market value.Merck is also one of the nation’s largest donors to UNICEF. One of the ways that Merck has partnered with UNICEF is by donating a drug called Mectizan. Mectizan is a drug that Merck has developed to fight river blindness, and Merck has teamed up with UNICEF in order to distribute Mectizan to anyone who needs it (Unicef, 2013). But the business strategies for Merck have not always been as ethically sound as it may appear. On September 30th 2004 the drug that Merck had created to treat arthritis and severe pain, Vioxx, was pulled off the shelves for good.The reason behind shutting down this drug was that it was found to have caused serious illnesses after long term use, including heart attacks and strokes (Kay, 2004). Vioxx was withdrawn only five years after being introduced, but in that short time had effected many, in those five years there had been over eighty million prescriptions for Vioxx (Kay, 2004). Dr David Graham, the as sociate director for science and medicine at the Office of Drug Safety, estimates that Vioxx caused between 88,000 and 139,000 heart attacks, of which thirty to forty percent have most likely died (Kay, 2004).But did Merck know of this threat before they started to market the drug? Before Merck released Vioxx in 1999 their own scientist conducted tests on Vioxx while developing it. In 1997 these scientist did a study and found that patients who were being tested on were six times more likely to have heart complications when using Vioxx compared to other arthritis drugs. But this study was never released and the data was never sent to the FDA (Culp & Isobel, 2007).Scientist also completed a VIGOR (Vioxx Gastrointestinal Outcomes Research) test on the drug and found evidence that people who take Vioxx had a five times higher chance of having a heart attack (Cahana & Mauron, 2006). In 2001 Merck scientist had another test called â€Å"meta-analysis†. The meta-analysis tested 20, 000 patients, and again showed that these patients were twice as likely to have a heart attack while taking Vioxx compared to other drugs (Culp & Isobel, 2007). Not only did Merck know about these risks and kept the results to themselves, they also trained their sales people on how to dodge the subject.In order to train the sales force who were going to be selling Vioxx to doctors, Merck developed a card game called dodgeball. The purpose of this game was to teach the sales force different ways to dodge questions asked by doctors about the effects Vioxx has on the heart (Daily, 2005). This again proves that Merck knew of these risks caused by taking Vioxx, but was trying to make sure that information was kept in house. Another instance where Merck lacked good ethical decision making is when they decided to pay Elsevier to publish a magazine for them. Elsevier is a publishing company that focuses mainly on medical and scientific literature.Merck’s marketing team decided to pay Elsevier to publish a journal called The Australiasian Journal of Bone & Joint Medicine. This journal was made to look like any other peer-reviewed medical journal but it was far from it. Merck’s marketing department handpicked the articles that they wanted to put in this journal, with the purpose of trying to control what articles were chosen to be in the journal. They took advantage of this situation by picking articles that favored Merck products and disguising this marketing scheme as a peer review journal (Grant, 2009).For instance in the second issue twenty one of the twenty nine articles spoke about Merck’s products in a favorable way, nine of them positively talking about Vioxx (Grant, 2009). Merck also had an ethical downfall when management decided to change the prices of their product. Not only was Merck paying doctors to prescribe Merck medicine when patients were in the hospital, Merck also started to give hospitals a ninety two percent discount on their medicine; with the idea that after the patient was discharged they would want to stay on the same medicine (Merck to pay whistleblower, 2008).The insurance company would pay full price for the drugs after the patient was discharged and that is where Merck would bring in their profit. An employee within Merck saw what was going on and didn’t approve. A lawsuit quickly followed and Merck ended up paying $671 million, including sixty eight million dollars to the whistleblower (Merck to pay whistleblower, 2008). Even after settling Merck did not think they were in the wrong with this pricing, as Merck to pay whistleblower (2008) reported Merck making a statement saying they â€Å"stands by its pricing strategies but is keen to resolve the dispute† (p. 2). Unfortunately for Merck, Vioxx isn’t the only drug that has caused people to question Merck’s ethical decision making when it comes to their customers. As noted above, Merck released a drug called Propecia t o the public that helped men with baldness. The problem with Propecia is that men are starting to see a great increase in sexual problems. Merck says that only one out of fifty men will see significant sexual side effects, and those side effects will disappear after you stop taking Propecia (Thornton, 2011). But that doesn’t seem to be the case.A recent study by Micheal Irving showed that ninety percent of his test patients still showed signs of sexual problems forty months after being off of Propecia (Thornton, 2011). This is where ethics will hurt Merck the most. Not only have there been hundreds of millions of dollars in fines and settlements that will be paid out, but if Merck continues to keep making unethical managerial decisions, Merck will lose the trust of their customers. Even though there is no evidence yet that Merck knew that Propecia would harm people after they stopped taking the drug, it’s hard not to think of how the Merck management decided to handle Vioxx.The financial hit is a big blow that will slow present and future projects, but money is a lot easier to gain back than trust. References Berman, J. (2011, June). UPS and Merck extend relationship with a global supply chain focus. Retrieved February 2013, from http://www. logisticsmgmt. com/article/ups_and_merck_extend_relationship_witha_ global_supply_chain_focus/ businesswire. (2011, June). UPS and Merck Expand Their Distribution and Logistics Agreement. Retrieved February 2013, from businesswire. com: http://www. businesswire. com/news/home/20110628005271/en/UPS-Merck-Expand-Distribution-Logistics-AgreementCahana, A. , & Mauron, A. (2006). The story of Vioxx—no pain and a lot of gain: ethical concerns regarding conduct of the pharmaceutical industry. Journal of anesthesia,  20(4), 348-351. doi:10. 1007/s00540-006-0432-7 Culp, D. R. , & Isobel, B. (2007, August 6). Merck and the Vioxx       debacle. Retrieved February 13, 2013 from St. Johns University,       Web site: http://www. stjohns. edu/media/3/2c0778b7593f4a178b60354abc80bad8. pdf Grant, B. (2009, April 30). Merck published fake journal. Retrieved Febuary 12, 2013 from, Web site: http://www. the-scientist. om/? articles. view/articleNo/27376/title/Merck- published-fake- journal/ Daily, M. (2005, July 18). Merck used ‘dodge ball’ on Vioxx       questions-lawyer. Retrieved February 12, 2013 from, Web site:       http://www. redorbit. com/news/general/178738/ Kay, J. ( 2004, November 22). The Vioxx scandal: Damning senate       testimony reveals drug company, government complicity. Retrieved 2013, February 9 from , Web site: http://www. wsws. org/en/articles/2004/11/viox-n22. html Merck & Co. , Inc. International Directory of Company Histories. 2000.Retrieved February 19, 2013 from Encyclopedia. com:  http://www. encyclopedia. com/doc/1G2-2843800076. html Merck Sharp & Dohme Corp. , a subsidiary of  Merck & Co. , Inc. (2009-2013). Retrieved February 18 , 2013, from http://www. merck. com/index. html Merck to pay whistleblower. (2008). TCE: The Chemical Engineer, (801), 12. Miller, C. , & Goldman, K. (2003, October, 23). Merck, aids, and       Africa. Retrieved February 2, 2013 from New York University,       Leonard N. Stern School of Business Web site: http://pages. stern. nyu. edu/~lcabral/teaching/aids. pdf Muse, L.A. (2011). Flexibility implementation to a global workforce: a case study of Merck and Company, Inc. Community, Work & Family,  14(2), 249-256. Singer, N. (March 9, 2009). Merck to Buy Schering-Plough for $41. 1 Billion. The New York Times, Retrieved from http://www. nytimes. com/2009/03/10/business/10drug. html? _r=0 February 19, 2013. Thornton, J. (2011). A Hair-Raising Side Effect. Men's Health (10544836), 26(10), 102-105. Unicef (2013). Merck & co. , inc. Retrieved January 12, 2013 from, Partners Web site       http://www. unicefusa. org/partners/corporate/merck. html

Studying Deviance from a Socio-cultural Stance

Robert K. Merton describes deviance as a unaccepted means of attaining socially important goals. His term innovation requires the person to obtain such goals (wealth, power, etc†¦) in socially unacceptable means, therefore placing the person in the category of a deviant. The strengths of looking at deviance in criminology are the boundless resources of sociologists and other social scientists such as Merton, Emile Durkheim, and George Herbert Mead.Their works are timeless and to the point as they do not need to reflect the current state of societies and instead only the underlying conflict theories from that school of thought that they represent. They are complimentary to current studies, but herein lies the weakness and that is the ever-changing actors and states in societies that need to be studied. The most important factor is the socio-cultural root of socially important goals that deviancy holds many times for the criminal.Those born into poverty and those whose ethnicity o r other minority status puts them into societal disadvantage may innovate ways to achieve simple survival when economies fail them. These socio-cultural roots need to be further explored. The past decade has shown more minority arrests on the part of women and black men, for example. A research study done by the National Institute of Justice suggests that rates of violent crimes by women is on the increase and the term â€Å"marginalized† is used to possibly explain that the most vulnerable women (those who are victims of crimes perpetuated by others) are most likely to commit crimes themselves.But the weakness is the absence of explanation as to why now this is a growing problem as women have always held minority status, but have not shown this level of deviancy. Black men are another group that is disproportionately incarcerated in relation to whites. The question may be of what is the rate of arrest vs. conviction? Is it that these minority populations are being arrested a t higher rates and inevitably convicted due to the financial strain of defense and, in fact deviancy has not changed, arresting attitudes have changed?Research is of the utmost importance in revealing these answers. At any rate these are socio-cultural issues, as is the issue of the images and glamorization of crime in some groups. Pierce and Singleton (1995) suggest that in young African American youth achieving is related to a sense of competence and that that competence represents a sense of control over their possibly out-of-control environments.Innovation then is transformed into deviancy when control and competence is the desired outcome. Looking at conflict theory and economics is the key to understanding this, but it does make it difficult for the Criminologist, as he or she must look to the current state of affairs in a society and look back to theories; sometimes in other disciplines to comprehend deviancy. Studies must be done on motivation and perception, which are highl y psychological.Organizational Behavior offers insight into, such deviant topics as gangs and recruitment, etc†¦Political Science may be utilized to look at other comparable societies to one’s own and the crime rate in relation to regime/regime change and other political factors. Theology (and the Protestant Ethic, for example) may offer insight into deviancy of past and present, as well. But, most importantly a Criminologist must understand the socio-cultural roots, stereotypes, and cultural bias that exists in his/her own community of interest to understand deviancy as innovation and the roots of all this. References Eitzen, D. S.   Phi Delta Kappan. April 1992.   â€Å"Problem Students: The Sociocultural Roots†.   p.587. Mead, G.H. (1918) â€Å"The Psychology of Punitive Justice†, American Journal of Sociology 23: 577-602. National Institute of Justice.   (1999).   â€Å"Research on Women and Girls in the Justice System: Plenary Papers of the 1999 Conference on Criminal Research and Evaluation-Enhancing Policy and Practice Through Research†. Volume 3. Pierce, W.J. & Singleton, S.M.   (1995).   â€Å"Improvisation as a concept for understanding and treating violent behavior among African American youthâ€Å". Families in Society. 76(7).   pp.444-450.